These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 10280289

  • 1. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM, McGrath ME, Schindel LP.
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [Abstract] [Full Text] [Related]

  • 2. A survey of selective administration procedures in formulary maintenance.
    Quigley MA, Brown WM.
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [Abstract] [Full Text] [Related]

  • 3. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L, Hutchinson R.
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [Abstract] [Full Text] [Related]

  • 4. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW.
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA.
    Pharmacotherapy; 1991 Mar; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [Abstract] [Full Text] [Related]

  • 6. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
    Crane VS.
    Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
    [Abstract] [Full Text] [Related]

  • 7. Developing an effective P&T Committee, Part I.
    Abramowitz PW, Godwin HN, Latiolais CJ, McDougal TR, Miller WA, Ravin RL.
    Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920
    [Abstract] [Full Text] [Related]

  • 8. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME.
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [Abstract] [Full Text] [Related]

  • 9. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ, Mykita L, Brown K.
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [Abstract] [Full Text] [Related]

  • 10. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW, Keith TD, Foster MT.
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost containment through P & T committee drug utilization review.
    Bender FH, DeMatteo CS.
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [Abstract] [Full Text] [Related]

  • 13. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ, Summerfield MR.
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [Abstract] [Full Text] [Related]

  • 14. Savings achieved through cephalosporin surveillance.
    Katz E, Schlamowitz S.
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [Abstract] [Full Text] [Related]

  • 15. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R, Gousse GC, Chow MS.
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH, Szeinbach SL.
    Clin Ther; 1993 Mar; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.